Image_1_Ophthalmic findings of congenital insensitivity to pain with anhidrosis with a novel neurotrophic tyrosine kinase receptor type 1 gene mutation: A case report.JPEG by Rong Zhu (172093)

“…<p>We report a case of congenital insensitivity to pain with anhidrosis (CIPA) with a novel neurotrophic tyrosine kinase receptor type 1 (NTRK1) gene mutation. …”

OsNF-YAs suppress JA signaling. by Xiaoxiang Tan (12542842)

Spheroid size changes due to primary mucus reduction hits and mucus changes due to primary swell hits. by Pranjali Beri (14945400)

<b>Effect of a Dietary Intervention on Insulin Requirements and Glycemic Control in Type 1 Diabetes: </b><b>A 12-Week Randomized Clinical Trial</b> by Hana Kahleova (618836)

Pharmacological characterization of the UT-mediated inhibition of the GABA_AR currents. by Laurence Desrues (167370)

“…<p>(A) Whole-cell current response to Iso (10⁻⁴ M, 2 s) recorded in the absence or presence of the benzodiazepine site inverse agonist DMCM (10⁻⁵ M), <i>h</i>UII and URP (10⁻⁸ M, each), or UT antagonists [Orn⁵]-URP and palosuran (10⁻⁶ M, each) in CHO expressing α₂, β₃ and γ₂ subunits. …”

Counterion Blockade in a Heterogeneously Charged Single-File Water Channel by Shusong Zhang (470905)

“…We rationalize the ionic transport using 1D Kramers’ escape theory framework, which describes nonlinear ionic current and the impact of surface charge density on the <i>I</i>–<i>V</i> curves. …”

Immunohistochemical staining in each group. by Yue Yang (52715)

“…<p>Increase in the frequency with same amount of treadmill exercise decreased the MIA-induced degradation of COL2A1 in articular cartilage and reduced the expression of MMP-13 and NF-κB p65. …”

Supplementary Material for: Effects of wearing hearing aids on gait and cognition: A pilot study by figshare admin karger (2628495)

“…Furthermore, reduced fear of falling and increased WHO-5 scores were observed after one year of HA use. …”

The geometry of the lactation curve based on Wood's equation: a two-step prediction by Jhone Gleison de Oliveira (10446485)

Kaplan Meier curves of OS and PFS according to d-dimer values comparing OS rates between patients with D-dimer levels ≤ 0.3 µg/mL and those with levels > 0.3 µg/mL. by Huriye Senay Kiziltan (22298378)

CPA treatment lowered activated caspase 3 and GFAP levels while DPCPX increased activated Caspase 3 and GFAP levels. by Manuel Soliño (5410001)

“…F) Quantification of C3a by WB. DPCPX produced a highly significant rise in C3a relative density compared to CTL (1.85±0.5 vs 1.01±0.07; unpaired Student´s t-test; p<0.01; n = 4), **p<0.01.…”

A comprehensive study of glucose and oxygen gradients in a scaled-down model of recombinant HuGM-CSF production in thermoinduced <i>Escherichia coli</i> fed-batch cultures by Greta I. Reynoso-Cereceda (18501789)

“…</p> <p></p><p>Thermoinduced recombinant <i>E. coli</i> grew less in a two-compartment scale-down model.</p><p>Heat-inducible <i>E. coli</i> cultures at a large scale significantly decrease recombinant protein production.…”

Succinate Dehydrogenase Is a Direct Target of Sirtuin 3 Deacetylase Activity by Lydia W. S. Finley (209240)

“…</p> <h3>Methodology/Principal Findings</h3><p>In this study, we performed a proteomic screen to identify SIRT3 interacting proteins and identified several subunits of complex II and V of the electron transport chain. …”

Image1_An Examination of the Techno-Economic Viability of Hybrid Grid-Integrated and Stand-Alone Generation Systems for an Indian Tea Plant.jpg by M. Thirunavukkarasu (12099583)

“…The PV/biomass-CHP/hydro/TLC hybrid system has the lowest LCOH of −$64.5/kg with a maximum renewable fraction of 96% in on-grid systems. …”

Image_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_3_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Table_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.docx by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Table_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.docx by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_2_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”